Unaudited Consolidated Statements of Operations
| Three Months Ended | Years Ended | |||||||||||||||
| (in $M, except per share amounts) | December 31, 2020 | December 31, 2021 | December 31, 2020 | December 31, 2021 | ||||||||||||
| Revenue | $ 1,062 | $ 1,847 | $ 4,851 | $ 6,585 | ||||||||||||
| Cost of sales | 1,280 | 1,463 | 5,563 | 5,572 | ||||||||||||
| Gross profit (loss) | (218 ) | 384 | (712 ) | 1,013 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 116 | 130 | 476 | 478 | ||||||||||||
| Sales, marketing, general and administrative | 136 | 167 | 445 | 595 | ||||||||||||
| Total operating expenses | 252 | 297 | 921 | 1,073 | ||||||||||||
| Impairment charge | 21 | — | 23 | — | ||||||||||||
| Total other operating charges | 21 | — | 23 | — | ||||||||||||
| Operating profit (loss) | (491 ) | 87 | (1,656 ) | (60 ) | ||||||||||||
| Finance expense, net | (38) | (26) | (151) | (108) | ||||||||||||
| Other income (loss) | 13 | 8 | 444 | (8) | ||||||||||||
| Income tax benefit (expense) | (8) | (26) | 12 | (78) | ||||||||||||
| Net income (loss) | (524 ) | 43 | (1,351 ) | (254 ) | ||||||||||||
| Earnings (loss) per share: | ||||||||||||||||
| Basic | $(1.05) | $0.08 | $(2.70) | $(0.50) | ||||||||||||
| Diluted | $(1.05) | $0.08 | $(2.70) | $(0.50) | ||||||||||||
| Shares used in earnings (loss) per share calculation | ||||||||||||||||
| Basic | 500 | 522 | 500 | 506 | ||||||||||||
| Diluted | 500 | 540 | 500 | 506 | ||||||||||||
Unaudited Consolidated Statements of Financial Position
